🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Yun-Li Huang

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Bis-benzylidine Piperidone RA190 treatment of hepatocellular carcinoma via binding RPN13 and inhibiting NF-κB signaling”.

Bis-benzylidine Piperidone RA190 treatment of hepatocellular carcinoma via binding RPN13 and inhibiting NF-κB signaling

BMC Cancer(2020)10.1186/s12885-020-06896-0
N/A
0DataRank · unranked
20 citations

Ravi Anchoori, Richard B.S. Roden, Rou‐Ling Cho, Yi-Chan Chen, Sheng-Chieh Tseng +4 more

Bis-benzylidine Piperidone RA190 Treatment of Hepatocellular Carcinoma via Binding RPN13 and Inhibiting NF-κB Signaling

Research Square(2020)10.21203/rs.2.18702/v4
N/A
0DataRank · unranked
0 citations

Ravi Anchoori, Richard B.S. Roden, Rou‐Ling Cho, Yi-Chan Chen, Sheng-Chieh Tseng +4 more

Bis-benzylidine Piperidone RA190 Treatment of Hepatocellular Carcinoma via Binding RPN13 and Inhibiting NF-κB Signaling

Research Square(2020)10.21203/rs.2.18702/v2
N/A
0DataRank · unranked
0 citations

Anchoori Ravi, Richard Roden, Rou‐Ling Cho, Yi-Chan Chen, Sheng-Chieh Tseng +4 more

Bis-benzylidine Piperidone RA190 Treatment of Hepatocellular Carcinoma via Binding RPN13 and Inhibiting NF-κB Signaling

Research Square(2020)10.21203/rs.2.18702/v3
N/A
0DataRank · unranked
0 citations

Ravi Anchoori, Richard B.S. Roden, Rou‐Ling Cho, Yi-Chan Chen, Sheng-Chieh Tseng +4 more